[1]
ChandhokN. and SaifM. 2014. Updates on the Use of Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer. JOP. Journal of the Pancreas. 15, 2 (Mar. 2014), 91-94. DOI:https://doi.org/10.6092/1590-8577/2303.